What is Piramal Alternatives India Credit Opportunities Fund II's investment strategy?
Piramal Alternatives India Credit Opportunities Fund II is covered in Rupeia's private credit research universe. The current public record describes the strategy as Performing private credit; growth and refinancing capital, with a sector focus of Healthcare, pharmaceuticals, industrials, consumer and automotive. The profile should be read with the linked source trail and Typical route: Category II AIF context.
What portfolio evidence is available for Piramal Alternatives India Credit Opportunities Fund II?
The profile displays only company or asset names attributable to Piramal Alternatives India Credit Opportunities Fund II in the reviewed public sources: Saimirra Innopharm; JRG Automotive Industries; Kolors Healthcare. It does not represent a complete current portfolio unless the manager has published one.
What is known about Piramal Alternatives India Credit Opportunities Fund II's performance or track record?
Piramal’s 2025 Saimirra announcement called the investment the third PCF II investment; the manager’s 2026 JRG announcement described JRG as the fourth infusion, and the August 2026 Kolors announcement identified another PCF II investment. Piramal also reported a maiden exit from its second performing-credit fund with a 20.4% IRR, but does not disclose audited fund-level net return measures. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
What are Piramal Alternatives India Credit Opportunities Fund II's fund size, fees and minimum investment?
Public fund size: ₹2,000 crore target domestic fund-raise including a ₹500 crore green-shoe option, as reported by Nuvama Wealth; final close amount is not publicly disclosed.. Public terms or access information: Category II AIF; sector-agnostic performing private credit; three-to-four-year investment horizon in mid-market corporates. Public materials do not disclose management fee, carry, hurdle, full term, recycling or investor waterfall terms.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
Who is on Piramal Alternatives India Credit Opportunities Fund II's investment team?
The current source record names Abhishek Jain (Co-Head, Performing Credit Fund); Anant Khatri (Co-Head, Performing Credit Fund); Kalpesh Kikani (CEO, Piramal Alternatives). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
What risks should be reviewed before investing with Piramal Alternatives India Credit Opportunities Fund II?
Review borrower concentration, security and seniority, cash versus accrued income, defaults, recoveries, fund leverage and liquidity. The current open diligence point is: The manager has publicly identified three PCF II investments and described the vehicle as having made four investments by July 2026, but it does not publish the complete borrower schedule, audited net returns, DPI, TVPI, fees, carry or current NAV..
What is the latest public update on Piramal Alternatives India Credit Opportunities Fund II?
2026-08-26: Piramal Alternatives announced a ₹215 crore PCF II investment in Kolors Healthcare on 2026-08-26, following a ₹125 crore PCF II investment in JRG Automotive Industries announced in July 2026. The manager’s current public materials identify PCF II as a dedicated performing-credit fund.
